Adherium Limited signs its first UK distribution agreement with Helicon Health

MELBOURNE: Adherium Limited, a leader in respiratory eHealth, remote patient monitoring and data management solutions, has signed its first UK distribution agreement with Helicon Health Ltd to sell the Hailie sensor range and cloud data services.

Adherium’s Hailie digital smart inhaler attaches to a patient’s Asthma or COPD medication inhaler and connects via the Hailie app to Helicon’s comprehensive remote patient monitoring platform. The combination creates, for the first time, the most advanced quality care for respiratory patients that are on Virtual Wards, at home and in any other remote setting.

Adherium’s Hailie sensors monitor medication adherence and the new, next generation sensors, provide actionable data about technique and physiology for the clinical team to make timely decisions on patient care.

Helicon Health is a medical technology development company, a NHS-focused contract research partner and specialised medical device accelerator.

Helicon Health was originally spun-out from the UCL Centre for Health Informatics and Multi Professional Education (CHIME). Helicon Health is supporting integrated care systems in the development of “learning health systems” by enabling the ethical collection of real-world data for analysis and interpretation for real world evidence to inform translation into better outcomes for patients and more effective use of scarce resources.

Initially founded to support the care of those that require at home care for conditions such as cardiovascular disease, cancer, diabetes and dementia, Helicon has accelerated and expanded its offering for respiratory, paediatric, neo natal and trauma networks through partnerships to deliver healthcare virtually.

The signing of this distribution agreement for an initial three-year term follows the recent appointment of Francis White as Vice President of Global Business Development and cements Adherium’s growth strategy to partner with leading players globally across strategically important geographies especially in the USA and UK to expand its footprint and deliver enhanced remote patient care.

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *